Cancer Immunotherapy Insights from ASCO
The Cancer Research Institute (CRI) hosts a Twitter Chat titled "Cancer Immunotherapy Insights from ASCO" on Tuesday, June 11, 2019 from 12:00-1:00 p.m. ET on the hashtag #CIMchat. The Twitter chat is moderated by Sharon Begley (@sxbegle), Senior Science Writer, STAT.
Read the Twitter Chat Recap on our Blog
With breaking news coming out of the American Society for Clinical Oncology meeting the previous week, there is much to discuss about this unique approach to cancer treatment that unleashes the immune system’s ability to detect and eliminate cancer cells. From research highlights and new combination therapies, to biomarkers and side effects, Twitter's leading immunologists and analysts discuss the field's issues and global impact.
How you can participate
- Sign in to your Twitter account, or if you don’t have one, register for a free one today at www.twitter.com.
- Follow Cancer Research Institute on Twitter @CancerResearch
- Search the hashtag: #CIMchat
- Join in the conversation! Read what others are saying about cancer immunotherapy and tweet in with your questions or comments.
Let us know if you're participating in advance by emailing firstname.lastname@example.org.
Sharon Begley (@sxbegle), is a senior science writer at STAT, covers genetics, cancer, neuroscience, and other fields of basic biomedical research. She was previously the senior health and science correspondent at Reuters, the science columnist at the Wall Street Journal, and the science editor at Newsweek. Among her favorite awards are an honorary doctorate from the University of North Carolina and the Public Understanding of Science Award from the Exploratorium in San Francisco. She is delighted to have moved to Boston but wonders why no one warned her about the Green Line.
We feature this Twitter chat as part of our seventh annual global awareness campaign, Cancer Immunotherapy Month, in June 2019.